Biotech Stock Mailbag: Fibrocell Science
Biotech Stock Mailbag: Fibrocell Science The Street
View Article4 Pharma Stocks That Should See a Surge in Interest Next Week
4 Pharma Stocks That Should See a Surge in Interest Next Week Seeking Alpha
View ArticleFibrocell Receives FDA Approval for LaViv
Fibrocell Receives FDA Approval for LaViv TheStreet.com
View ArticleBusy Week for FDA Leads to Volatile Action in 5 Pharma Stocks
Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks Seeking Alpha
View ArticleEncouraging Pipelines From Pluristem and Fibrocell Science Gain Attention
Encouraging Pipelines From Pluristem and Fibrocell Science Gain Attention Yahoo/MarketWire
View ArticleFACTBOX-Stem cell advances focus on heart, inflammation
FACTBOX-Stem cell advances focus on heart, inflammation Reuters
View ArticleInvesting In The Stem Cell Sector: An Overview
Investing In The Stem Cell Sector: An Overview Seeking Alpha
View ArticleFibrocell Science Board of Directors Accepts Resignation of Chief Operating...
Fibrocell Science Board of Directors Accepts Resignation of Chief Operating Officer and Chief Financial Officer Declan Daly Yahoo/BusinessWire
View ArticleFibrocell Science Steadies Itself For Growth After Listing On NYSE
Fibrocell Science Steadies Itself For Growth After Listing On NYSE Seeking Alpha
View ArticleFIbrocell Science Announces Exclusive Technology License Agreements with UCLA...
FIbrocell Science Announces Exclusive Technology License Agreements with UCLA to Advance the Development of Personalized Cell Therapies Motley Fool
View Article
